Alvarez, R., Reguero, J., Batalla, A., Iglesias-Cubero, G. et. al., 1998. “Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease,” Cardiovascular Research, Vol.40, pp.375-79

Beige, J., Hohenbleicher, H., Distler, A., Sharma, A., 1999. “G-protein β3 subunit C825T variant and ambulatory blood pressure in essential hypertension,” Hypertension, Vol.33, pp.1049-1051

Berge, K., Berg, K., 1994. “No effect of insertion/deletion polymorphism at the angiotensin I-converting enzyme locus on normal blood pressure levels or variability,” Clin. Genet., Vol.45, pp.169-74

Bengtsson, K., Orho-Melander, M., Melander, J., Lindblad, U. et. al., 2001. “β2-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes,” Hypertension, Vol.37, pp.1303-308

Benjafield, A., Jeyasingam, C., Nyholt, D., Griffiths, L. et. al., 1998. “G-protein β3 subunit gene (GNB3) variant in causation of essential hypertension,” Hypertension, Vol.32, pp.1094-097

Bohn, M., Berge, K., Bakken, A., Erikssen, J. et. al., 1993. “Insertion/deletion polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction,”  Clin. Genet., Vol.44, pp.292-97

Bonnardeaux, A., Davies, E., Jeunemaitre, X., Fery, I. et. al., 1994. “Angiotensin II type I receptor gene polymorphism in human essential hypertension,” Hypertension. Vol.24, pp.63-69

Brand, E., Hermann, S., Nicaud, V., Ruidavets, J. et. al., 1999. “The 825C/T polymorphism of the G-protein subunit β3 is not related to hypertension,”  Hypertension, Vol.33, pp.1175-178

Cambien, F., Poirier, O., Lecerf L., Evans A. et. al., 1992. “Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction,” Nature, 359. pp.641-44

Celermajer, D., Sorensen, K., Gooch, V., Spiegelhalter, D. et al., 1992. “Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis,” Lancet. 340. pp.1111-115

Corretti, M., Anderson, T., Benjamin, E., Celermajer, D. et al., 2002. “Guidelines for the ultrasound assessment of endothelial dependent flow-mediated vasodilation of the brachial artery. A report of the international brachial artery reactivity task force, ” J Am Coll Cardiol., 39, pp.257-265

Demirel, S., Akkaya, V., Cine, N., Oflaz, H. et. al., 2005. “Genetic polymorphisms and endothelial dysfunction in patients with essential hypertension: a cross-sectional case-control study,” Neth. Heart. J., Vol.13, pp.126-31

 

Dhamrait, S., Paine, J., Li, P., Jones, A. et. al., 2003. “Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension,” Eur. Heart. J., Vol.24, pp.1672-680

Dong, Y., Zhu, H., Sagnella, G., Garter, N. et. al., 1999. “Association between the C825T polymorphism of the G protein β3-subunit gene and hypertension in blacks,” Hypertension, Vol.34, pp.1193-196

Izawa, H., Yamada, Y., Okada, T., Tanaka, M. et. al., 2003. “Prediction of genetic risk for hypertension,” Hypertension, Vol.41, pp.1035-1040

Jeunmaitre, X., Lifton, R., Hunt, S., Williams. R. et. al., 1992. “Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension,” Nature Genet., Vol.1, pp.72-75

Jeunemaitre, X., Soubrier, F., Kotelevtsev, Y., Lifton, R. et. al., 1992. “Molecular basis of human hypertension: Role of angiotensinogen,” Cell, Vol.71, pp.169-80

Kearney, P., Whelton, M., Reynolds, K., Muntner, P. et al., 2005. “Global burden of hypertension: Analysis of worldwide data,” Lancet, Vol.365. pp.217-23

Kupari, M., Hautanen, A., Lankinen, L., Koskinen, P. et. al., 1998. ”Association between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function,” Circulation. Vol.97, pp.569-75

Linder, L., Kiowsky, W., Bühler, F., Lüscher, T., 1990. “Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension,” Circulation. Vol.81, pp.1762-767

O’Donell, C., Lindpainter, K., Larson, M., Rao, V. et. al., 1998. “Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with essential hypertension and blood pressure in men but not women in the Framingham Heart Study,” Circulation, Vol.97, pp.1766-772

Panza, J., 1997. “Endothelial dysfunction in essential hypertension,” Clin Cardiol, Vol.11. pp.26-33

Panza, J., Quyyumi, A., Brush, J., Epstein, S., 1990. “Abnormal endothelium dependent vascular relaxation in patients with essential hypertension,” N. Engl J Med., 323, pp.22-27

Perticone, F., Ceravolo, R., Maio, R., Venmtura, G. et. al., 1998. “Angiotensin-converting enzyme polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients,” Hypertension, Vol.31, pp.900-905

 

Rossi, G., Taddei, S., Virdis, A., Ghiadoni, L. et. al., 2001. “Exclusion of ACE D/I gene polymorphism as a determinant of endothelial dysfunction,” Hypertension, Vol.37, pp.293-300

Rossi, G., Taddei, S., Virdis, A., Cavallin, M. et. al., 2003. “The T-786C and Glu298Asp polymorphism of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients,” J. Am. Coll. Cardiol., Vol.41, pp.946-48

Russ, A., Maerz, W., Rũzicka, V., Stein, U. et. al., 1993. “Rapid detection of the hypertension associated Met235Thr allele of the human angiotensinogen gene,” Hum. Mol. Genet. Vol.2, pp.609-10

Samani, N., Thompson, J., O’Toole, L., Channer, K. et. al., 1996. “A metaanalysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction,” Circulation, Vol.94, pp.708-12

Schunkert H., Hense H., Holmer S., Stender M. et. al., 1994. “Association between a deletion polymorphism of the angiotensin converting gene and left ventricular hypertrophy,” New. Eng. J. Med., Vol.30, pp.1634-638

Shioji, K., Kokubo, Y., Mannami, T., Inamoto, N. et. al., 2004. “Association between hypertension and the α-adducin, β1-adrenoreceptor, and G-protein β3 subunit genes in the Japanese population; the Suita study,” Hypertens. Res.,Vol.27, pp.31-37

Siffert, W., Rosskopf, D., Siffert, G., Busch, S. et. al., 1998. “Association of a human G-protein beta3 subunit variant with hypertension,” Nat. Genet., Vol.18, pp.45-48

Stein, J., Korcarz, C., Hurst, R., Lonn, E. et al., 2008. “Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: A consensus statement from the American society of echocardiography carotid intima-media thickness task force endorsed by the society for vascular medicine,” J. Am. Soc. Echocardiogr., Vol.21, pp.93-111

Tiret, L., Bonnardeux, A., Poirier, O., Ricard, S. et. al., 1994. “Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on risk of myocardial infarction,” The Lancet, Vol.344, pp.910-13

Turner, S., Boerwinkle, E., Sing, C., 1999. “Context-dependent associations of the ACE I/D polymorphism with blood pressure,” Hypertension, Vol.34, pp.773-78

 

Zateyshchikov, D., Minushkina, L., Kudryashova, O., Chistyakov, D., 2000. “NO-synthase gene and endothelium-related hemostasis in patients with coronary heart disease,” Kardiologiya, Vol.11, pp.28-32

Zee, R., Lou, Y., Griffiths, L., Morris, B., 1992. “Association of a polymorphism of the angiotensin I-converting enzyme with essential hypertension,” Biochem. Biophys. Res. Commun., Vol.184, pp.9-15